$CAMP
CAMP4 Therapeutics Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.24
▲+5.21%+$0.210
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCAMP4 Therapeutics Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CAMP up today? It is at $4.24 (+5.21%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CAMP spikes, and full due diligence on CAMP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CAMP 11 times in the last 30 days. Create a free account to track $CAMP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CAMP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CAMP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 2, 2026 · 18 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Gold Kelly Officer | Bought (open market) | +10K 0.02% of company | n/a | 10K | $40K at $3.96 | Aug 31, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -400K 0.6% of company | sold 7.0% | 5.28M | $1.6M at $4.04 | Aug 27, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -10 | sold <0.1% | 5.68M | $45 at $4.50 | Aug 24, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -32K 0.05% of company | sold 0.6% | 5.68M | $144K at $4.50 | Aug 21, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -115K 0.2% of company | sold 4.4% | 2.47M | $521K at $4.54 | Aug 20, 26 |
Tardiff Daniel Officer | Sold (automatic/other) | -2K | n/a | n/a | $8K at $4.76 | Aug 19, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -45K 0.07% of company | sold 1.7% | 2.58M | $215K at $4.76 | Aug 19, 26 |
Mandel-Brehm Josh Officer | Bought (open market) | +7K 0.01% of company | added 2.4% | 285K | $11K at $1.65 | Aug 3, 26 |
Gold Kelly Officer | Bought (open market) | +7K 0.01% of company | added 9.7% | 74K | $11K at $1.65 | Aug 3, 26 |
Maricich Yuri Officer | Bought (open market) | +7K 0.01% of company | added 100% | 13K | $11K at $1.65 | Aug 3, 26 |
Young Richard A Director | Bought (open market) | +16K 0.03% of company | added 9.6% | 186K | $27K at $1.65 | Aug 3, 26 |
Young Richard A Director | Bought (open market) | +15K 0.02% of company | added 9.8% | 170K | $25K at $1.65 | Sep 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CAMP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CAMP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CAMP last traded at $4.24, up 5.21% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
CAMP4 Therapeutics Corporation Common Stock (CAMP) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CAMP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CAMP 11 times in the last 30 days.
CAMP (CAMP4 Therapeutics Corporation Common Stock) trades on XNAS, with a market cap of about $266M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CAMP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CAMP discussion
Sign in to ask a question or join the discussion.